Form 4: Medpace Holdings Director Fred B. Davenport Jr. Reports Stock Option Grant

Director Fred B. Davenport Jr. of Medpace Holdings, Inc. reports the acquisition of stock options and changes in beneficial ownership of common stock.

Summary

• On May 16, 2025, Fred B. Davenport Jr., a director of Medpace Holdings, Inc., reported transactions involving the company's securities.
• Davenport acquired 1,224 stock options with an exercise price of $305.66, exercisable starting May 16, 2025, and expiring on May 16, 2032.
• These options vest on the earlier of the day before the first annual meeting following the grant date or the first anniversary of the grant date, contingent on continued service on the board.
• Davenport also reported owning 2,998 shares of common stock directly and 2,000 shares indirectly through a trust.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing, so the sentiment is neither positive nor negative.

Positives

• The acquisition of stock options aligns the director's interests with those of the shareholders, incentivizing him to work towards increasing the company's value.

Industry Context

This filing is a routine disclosure related to insider transactions, common in publicly traded companies. It provides transparency regarding the compensation and holdings of company directors.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the director's holdings and incentives.

Key Dates

Keywords

Medpace Holdings, Director, Stock Options, Beneficial Ownership, Form 4, Securities, Davenport